Close Menu

NEW YORK (GenomeWeb) – OneOme announced today that it has partnered with Total Quality Medicine (TQM) to offer its pharmacogenomic testing and support services in Mexico.

Under the terms of the deal, OneOme's PCR-based RightMed genetic test — which covers 22 genes in which variants are known to contribute to the effectiveness or safety of more than 340 drugs for more than 20 indications — will be incorporated into Mexico City-based TQM's GeneTest line of personalized medicine products.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.